The Sumitomo Dainippon-Roivant Alliance will be wholly owned by Sumitomo, which is also taking control of five companies - and potentially six more - from Ramaswamy's Vant family of firms.
Enzyvant has claimed the second-ever Regenerative Medicine Advanced Therapy (RMAT) designation, a new regulatory program ushered in as part of the 21st Century Cures Act.
Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice